Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle

Gynecologic and Obstetric Investigation

Volumn 70, Issue 1, 2010, Pages 64-68

  Seow, Kok Min ^a,b   Lin, Yu Hung ^a,b   Hsieh, Bih Chwen ^a,b   Huang, Lee Wen ^a,b,c   Huang, Shih Chia ^a   Chen, Chin Yu ^a   Chen, Pei Hsin ^a   Tzeng, Chii Ruey ^c   Hwang, Jiann Loung ^a,c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cetrorelix; Implantation rate; IVF outcome; Subtle progesterone rise

Indexed keywords

CETRORELIX; GONADORELIN ANTAGONIST; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HORMONE DETERMINATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADULT; CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 77954902930     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000290062     Document Type: Article

References (17)

1. Oliveness F, Cunha-Filho JS, Fanchin R, Bouchard P, Frydman R: The use of GnRH antagonists in ovarian stimulation. Hum Re- prod Update 2002;8:279-290.
2. Smacklon N, Fauser BC: Regulation of follicle development and novel approaches to ovarian stimulation for IVF. Hum Reprod Update 2000;6:30\
3. De Jong D, Macklon NS, Fauser BC: A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the 'follicle-stimulating hormone window' combined with the gonadotropins-releasing hormone antagonist cetrorelix. Fertil Steril 2000;73:1051-1054.
4. Leroy I, d'Acremont M, Brailly-Tabard S, Frydman R, de Mouzon J, Bouchard P: A single injection of a gonadotropin-releasing hormone antagonist (cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge. Fertil Steril 1994;62:461-467.
5. Hwang JL, Huang LW, Hsieh BC, Tsai YL, Huang SC, Chen CY, Hsieh ML, Chen PH, Lin YH: Ovarian stimulation by clomiphene citrate and hMG in combination with cetro- relix acetate for ICSI cycles. Hum Reprod 2003;18: 45-49.
6. Felberbaum RE, Alano C, Ludwig M, Rieth- muller-Winzen H, Grigat M, Devroey P, Diedrich K: Ovarian stimulation for assisted reproduction with HMG and concomitant mid-cycle administration of the GnRH antagonist cetrorelix according to the multiple-dose protocol: a prospective uncontrolled phase III study. Hum Reprod 2000; 15:1015-1020.
7. Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R: Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090-1094.
8. Givens CR, Schriock ED, Dandekar PV, Martin M: Elevated serum progesterone levels on the day of human chorionic gonado- trophin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011-1017.
9. Harada T, Yoshida S, Katagiri C, Takao N, Ikenari T, Toda T, Mio Y, Terakawa N: Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonado- trophin-releasing hormone agonist and go- nadotrophin. Hum Reprod 1995; 10: 1060-1064.
10. Ubaldi F, Smitz J, Wisanto A, Joris H, Schi- etecatte J, Van Steirtegem A, Devroey P: Oocyte and embryo quality as well as pregnancy rate are not affected by high follicular phase serum progesterone. Hum Reprod 1995; 12: 102-108.
11. Ubaldi F, Albano C, Peukert M, Riethmul- ler-Winzen H, Camus M, Smitz J, Van Steirteghem A, Devroey P: Subtle progesterone rise after the administration of the go- nadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod 1996; 11:1405-1407.
12. Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remohi J, Pellicer A: Premature lu- teinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fer- til Steril 2003;80:1444-1449.
13. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC: Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007;13: 343-355.
14. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamiltron F, Meldrum DR: Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563-566.
15. Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P: Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Hum Reprod 2004; 19: 1525-1529.
16. Papanikolaou EG, Kolibianakis EM, Pozzo- bon C, Tank P, Tournaye H, Bourgain C, Van Steirtegem A, Devroey P: Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single-blastocyst transfer. Fertil Steril 2009;91:949-952.
17. Felberg D, Goldman GA, Ashkenazi J, Dicker D, Shelef M, Goldman JA: The impact of high progesterone levels in the follicular phase of in vitro fertilization cycles: a comparative study. J In Vitro Fert Embryo Transf 1989; 6: 11-14.